Semaglutide programs typically bundle injections with comprehensive support, including initial medical assessments, personalized nutrition plans, regular health monitoring (labs/measurements), dosage adjustments, and long-term maintenance strategies, all designed to manage appetite, promote fullness, and ensure safe, effective weight loss under professional guidance
Initial results from retatrutides first phase 3 trial (TRIUMPH-4) showed an average weight loss of 28.7% at 68 weeks on the highest dose (12 mg)
Combined with diet and exercise, study participants lost 15-20% of their body weight over 68 weeks on average
How effective is orforglipron for Type 2 diabetes management
However, safety and efficacy data in pregnancy remain limited